MedTrace Logo

RLE Outcomes With Bilateral Implantation of Odyssey IOLs

NCT06979557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-02-27

No results posted yet for this study

Summary

This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as measurement of visual acuities at distance, intermediate, and near, monocular (right eye) and binocular defocus curve, and refractive outcomes.

Conditions

  • Refractive Lens Exchange

Interventions

DEVICE

Odyssey IOL

Bilateral implantation with the Odyssey IOL

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Mann Eye Institute

    lead OTHER

Principal Investigators

  • Phillip Brunson, OD · Mann Eye Institute

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-21
Primary Completion
2026-01-01
Completion
2026-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06979557 on ClinicalTrials.gov